COVID-19: suspension of treatment with chloroquine in Tunisia (Jalila Ben Khalil)
27/05/2020 18:39, TUNIS/Tunisia
(TAP) - "The use of chloroquine in the treatment of patients with COVID-19 has been suspended in all hospitals in Tunisia," Jalila Ben Khalil, a member of the Standing Committee for the fight against coronavirus announced Wednesday.

In a statement to TAP, Ben Khalil justified this decision by the drop in the number of patients with COVID-19 in hospitals, reporting that as of May 26, 2020, only two patients are hospitalised out of a total of 74 active cases placed under surveillance.

The World Health Organisation (WHO) announced Monday the pausing of clinical trials with hydroxychloroquine which it is conducting with its partners in several countries, as a precautionary measure, following the publication of a study in the medical journal The Lancet deeming ineffective, even harmful, the use of chloroquine or its derivatives such as hydroxychloroquine against COVID-19.

400 thousand rapid tests

In addition, Jalila Ben Khalil pointed out that 400,000 rapid tests will be carried out on caregivers, security guards, the military and other specific sectors.

She also recalled the importance of maintaining physical distance and barrier gestures to preserve the positive results obtained in the fight against the spread of the virus in Tunisia especially as external threats remain persistent.

Surveys will be conducted after the rapid tests have been carried out in order to assess the overall epidemiological situation in Tunisia, - she added.

Twitter Updates Newsletter Signup Contact Us

To receive our newsletter,register

tel: 71889000
fax: 71883500, 71888999